Semaglutide (sold as Ozempic, Wegovy and Rybelsus) was initially developed to treat diabetes. It works by stimulating the production of insulin to keep blood sugar levels in check.
4 hours ago
0
0
The ratio of abortions carried out with medication rose to 63 percent between 2020 and 2023 in the United States, according to analysis published ahead of a Supreme Court hearing on restricting access to the pills.
Mar 19, 2024
0
0
A new review of available evidence led by researchers at the Harvard Pilgrim Health Care Institute suggests that female reproductive characteristics may be overlooked as risk factors that contribute to later metabolic dysfunction.
Jan 26, 2024
1
19
Indiana University neuroscientists have found the first evidence that rodents can call upon their episodic memory—the ability to recall seemingly unimportant streams of events from the past—and use incidentally encoded ...
Jan 12, 2024
0
62
Without representative participation, clinical trials cannot accurately reflect how medical interventions impact patients—introducing bias and affecting research quality. This can result in reluctance to offer treatments ...
Dec 12, 2023
0
0
Whether it's a question of analyzing medical images, detecting drug interactions, or creating brain-computer interfaces, it seems like the potential applications of artificial intelligence (AI) in the health care industry ...
Dec 5, 2023
0
15
Canadian scientists have established for the first time a new mechanism and role for LDL in the development of type 2 diabetes, beyond its traditional role in the development of cardiovascular disease in humans.
Nov 13, 2023
0
13
The Academy of Breastfeeding Medicine (ABM) has released new literature-based recommendations related to breastfeeding in the setting of substance use and substance use disorder (SUD) treatments. The new clinical protocol ...
Oct 23, 2023
0
1
An examination of how clinical trials have changed in Australia over the past 15 years has identified challenges such as lack of balance in the types of research, lack of collaboration among Australian researchers, and the ...
Aug 14, 2023
0
2
Transgender and nonbinary adults may be at higher risk of developing Alzheimer's disease—the most common form of dementia—in later life, due to key risk factors being more prevalent in this population.
Jul 27, 2023
0
11
